Adicet Bio, Inc.ACETNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 10 | 25 | 0 |
| Gross Profit | 10 | 25 | 0 |
| Operating Income | -61 | -73 | -152 |
| Net Income | -62 | -70 | -143 |
| EBITDA | -60 | -65 | -137 |
| EPS Diluted | -32.00 | -27.20 | -52.96 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 278 | 258 | 160 |
| Total Current Assets | 282 | 261 | 162 |
| Total Assets | 339 | 331 | 207 |
| Total Current Liabilities | 16 | 20 | 19 |
| Total Liabilities | 36 | 38 | 37 |
| Total Equity | 303 | 292 | 170 |
| Total Debt | 21 | 21 | 21 |
| Net Debt | -257 | -237 | -139 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -51 | -45 | -94 |
| Capital Expenditure | -13 | -17 | -4 |
| Free Cash Flow | -64 | -62 | -98 |
| Stock-Based Comp | 13 | 17 | 20 |
| Net Change in Cash | 189 | -20 | -98 |